bioRxiv preprint doi: https://doi.org/10.1101/2020.10.09.334086; this version posted October 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Integrative Analysis the characterization of peroxiredoxins in pan-cancer Lei Gao1†, Jialin Meng2†, Chuang Yue3†, Xingyu Wu3, Quanxin Su3, Hao Wu3, Ze Zhang3, Qinzhou Yu2, Shenglin Gao3*, Song Fan2*, Li Zuo3* 1Department of Urology, the Second Hospital of Hebei Medical University, Shijiazhuang, China 2Department of Urology, The First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University, Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, China 3 Department of Urology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China † Authors contributed equally to the study. Correspondence: Shenglin Gao:
[email protected] Song Fan:
[email protected] Li Zuo:
[email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.10.09.334086; this version posted October 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Peroxiredoxins (PRDXs) are antioxidant enzymes protein family members that involves the process of several biological functions, such as differentiation, cell growth. Considerable evidence demonstrates that PRDXs play critical roles in the occurrence and development of carcinomas.